View Press Releases
-
Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.
PRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc
Feb 25, 2020
-
LUNAC Therapeutics selects Domainex as its strategic drug discovery partner
CAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies
Feb 24, 2020
-
Streck to present new tube at TRI-CON
LA VISTA, NE - Feb 24, 2020 - Streck R&D Scientific Manager Dr. Nicholas George will give a presentation on our newest blood collection tube, RNA Complete BCT, at the 27th International Molecular Medicine Tri-Conference in San Francisco
Feb 24, 2020
-
Rare Disease Patient Platform Raremark Partners With TriNetX
CAMBRIDGE, MA - Feb 24, 2020 - TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community
Feb 24, 2020
-
Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis
GLASGOW, SCOTLAND - Feb 24, 2020 - Altair Medical, a medical technology company developing a groundbreaking solution to the global opioid crisis, today announce that the US Food and Drug Administration (FDA) has awarded the Company Breakthrough Device designation for its RESPMETER(TM) wearable biosensor device
Feb 24, 2020
-
Aalto Bio Reagents Launches First Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Protein
DUBLIN, IRELAND - Feb 24, 2020 - Aalto Bio Reagents today announced the availability of its new recombinant SARS-CoV-2 nucleocapsid protein (code CK 6404) for diagnostic test manufacturers, vaccine developers and researchers globally
Feb 24, 2020
-
Creative Diagnostics Introduces Innovative Zebrafish Antibodies
SHIRLEY, NY - Feb 25, 2020 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches a large range of antibodies against key immune molecules in zebrafish to enhance the research within the fish scientific community as well as mammalian immune disorders researches
Feb 23, 2020
-
Creative Proteomics Released BrdU Cell Proliferation Assay to Be Behind Researchers
SHIRLEY, NY - Feb 21, 2020 - February 21, 2020, since its establishment in 2004, Creative Proteomics has served nearly 2 million researchers from different areas, including clinical, academia and industry
Feb 20, 2020
-
Absolute Antibody Partners with the Technical University of Denmark to Offer Antibodies against Animal Venom Toxins
REDCAR, UK - Feb 20, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms
Feb 20, 2020
-
From Ending Addiction to Preventive Genomics, Bio-IT World 2020 Keynoters Share Data-Driven Approaches
NEEDHAM, MA, UNITED STATES - Feb 19, 2020 - Bio-IT World 2020, the premier conference and expo uniting life science, data science, informatics and IT leaders, today announced its Plenary Keynote sessions
Feb 19, 2020
-
Creative Biolabs Provides Anti-EGFR Therapeutic Antibody---Nimotuzumab for Research Use
SHIRLEY, NY, USE - Feb 19, 2020 - February 19, 2020, Creative Biolabs, as a leading supplier in the recombinant antibody field, announced that the nimotuzumab, a kind of anti-EGFR therapeutic antibody, is now available for research and clinical use
Feb 18, 2020
-
Greenphire and Roche Team to Address Critical Clinical Trial Patient Convenience Issues at 11th Annual SCOPE Summit
ORLANDO, FL, UNITED STATES - Feb 18, 2020 - Greenphire, the global leader in financial software for clinical trials, today announced that it has teamed with top industry sponsor, Roche (SIX: RO, ROG;OTCQX: RHHBY), to address the top hurdles patients face when participating in clinical trials
Feb 18, 2020
-
Signant Health invests for growth with the opening of its new Philadelphia-area office
PHILADELPHIA - Feb 18, 2020 - Signant Health, an industry-leading clinical research technology and solutions company, is proud to announce that it has officially opened a new, leading edge office facility in Blue Bell, Pennsylvania
Feb 18, 2020
-
Optibrium appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development
CAMBRIDGE, UNITED KINGDOM - Feb 18, 2020 - Optibrium, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business Development
Feb 18, 2020
-
Rho Announces Fifth Year as Smile Train Triathlon Title Sponsor
DURHAM, NC, UNITED STATES - Feb 17, 2020 - For Immediate Release Rho Announces Fifth Year as Smile Train Triathlon Title Sponsor The RTP-based Contract Research Organization will continue to show its support at the charity's 13th annual event in Wake Forest Research Triangle Park, NC ̶ February 17, 2020 ̶ Rho, an RTP-based full-service contract research organization (CRO) focused on bringing new products to market through a complete range of product development services, today announced it is the 2020 Title Sponsor of the 13th annual Smile Train Triathlon, taking place Sunday, June 28 in Wake Forest, North Carolina
Feb 17, 2020
-
Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing
PIOMBINO DESE, PADUA AND INDIANAPOLIS, ITALY - Feb 17, 2020 - Stevanato Group has announced a new partnership with Pfeiffer Vacuum Technologies to provide biopharma companies with advanced Container Closure Integrity (CCI) analysis and testing protocols
Feb 17, 2020
-
NVIDIA DGX-2 Systems Supplied by Microway Accelerate Research at Oak Ridge National Laboratory
PLYMOUTH, MA, UNITED STATES - Feb 14, 2020 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC, announces it has delivered 2 NVIDIA DGX-2 AI Systems to the US Department of Energy’s Oak Ridge National Laboratory (ORNL) that have since opened new opportunities and scientific results for machine learning and data-intensive computing groups
Feb 14, 2020
-
2 Industry Veterans Join TrialScope Connect™ Advisory Board
JERSEY CITY, NJ, US - Feb 13, 2020 - TrialScope announces the appointment of Craig Lipset and Scott Ballenger to the TrialScope Connect advisory board
Feb 13, 2020
-
The Open Wearables Initiative Expands Founding Team; Begins Soliciting Algorithms and Datasets for Wearable and Connected Health Technologies
CAMBRIDGE, MA - Feb 13, 2020 - Shimmer Research, a global leader in wearable technology for research applications, today announced that the Open Wearables Initiative (OWEAR) is now actively soliciting open source software and datasets from wearable sensors and other connected health technologies at www
Feb 13, 2020
-
Domainex announces the appointment of Tom Mander as Chief Executive Officer
CAMBRIDGE, UK - Feb 13, 2020 - Domainex Ltd is pleased to announce the appointment of Dr Tom Mander as Chief Executive Officer. Dr Mander will take over when Dr Trevor Perrior retires from the role in April 2020
Feb 13, 2020